HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CCR4
C-C motif chemokine receptor 4
Chromosome 3 · 3p22.3
NCBI Gene: 1233Ensembl: ENSG00000183813.8HGNC: HGNC:1605UniProt: A0N0Q1
123PubMed Papers
20Diseases
1Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Receptor
CLINICAL
FDA Approved Target
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
plasma membraneC-C chemokine receptor activityprotein bindingcell chemotaxismycosis fungoidesSezary's diseaseadult T-cell leukemia/lymphomaneoplasm
✦AI Summary

CCR4 is a G-protein-coupled chemokine receptor with dual roles in immune regulation and RNA metabolism. As an immune receptor, CCR4 functions as a high-affinity receptor for chemokines CCL17/TARC and CCL22/MDC, mediating Th2 cell and regulatory T cell (Treg) migration 1. CCR4 expression on Tregs is particularly elevated in tumor microenvironments, where it promotes their accumulation and immunosuppressive function 2. In pulmonary fibrosis, increased CCR4 expression on BAL CD4+ lymphocytes correlates with disease severity, suggesting pathogenic involvement in fibrotic inflammation 3. Beyond immunity, CCR4 functions as a catalytic subunit of the CCR4-NOT deadenylase complex, a central post-transcriptional regulator that removes poly(A) tails from mRNAs 4. YTHDF2 recruits CCR4-NOT to m6A-modified RNAs, promoting their degradation 5. Mammalian CCR4-NOT recognizes stalled ribosomes and couples translation to mRNA decay through ribosomal ubiquitination 6. During HCMV infection, host CCR4-NOT preferentially deadenylates cellular mRNAs while sparing viral transcripts, allowing viral gene expression dominance 7. These findings establish CCR4 as a therapeutic target in allergy, fibrosis, and cancer immunotherapy, while its deadenylase function represents a key control point in gene expression regulation.

Sources cited
1
CCR4 is preferentially expressed on Th2 cells and represents a therapeutic target for allergic diseases
PMID: 14561210
2
CCR4 is highly expressed on intratumoral Tregs and mediates their migration into the tumor microenvironment
PMID: 41370186
3
Increased CCR4 expression on BAL CD4+ lymphocytes correlates with disease severity in idiopathic pulmonary fibrosis
PMID: 16239626
4
CCR4 is a catalytic deadenylase that removes poly(A) tails from mRNAs as part of the CCR4-NOT complex
PMID: 34038562
5
YTHDF2 recruits the CCR4-NOT deadenylase complex to m6A-containing RNAs to promote their degradation
PMID: 27558897
6
Mammalian CCR4-NOT recognizes stalled ribosomes and ubiquitinates them to couple translation to mRNA decay
PMID: 37653243
7
Host CCR4-NOT preferentially deadenylates cellular mRNAs over viral transcripts during HCMV infection, supporting viral replication
PMID: 37846490
Disease Associationsⓘ20
mycosis fungoidesOpen Targets
0.54Moderate
Sezary's diseaseOpen Targets
0.52Moderate
adult T-cell leukemia/lymphomaOpen Targets
0.45Moderate
neoplasmOpen Targets
0.43Moderate
hypothyroidismOpen Targets
0.37Weak
Cutaneous T-cell lymphomaOpen Targets
0.35Weak
childhood onset asthmaOpen Targets
0.34Weak
trauma complicationOpen Targets
0.32Weak
cataractOpen Targets
0.32Weak
breast benign neoplasmOpen Targets
0.23Weak
hepatocellular carcinomaOpen Targets
0.21Weak
head and neck squamous cell carcinomaOpen Targets
0.21Weak
melanomaOpen Targets
0.20Weak
lung adenocarcinomaOpen Targets
0.20Weak
multiple sclerosisOpen Targets
0.19Weak
urinary bladder carcinomaOpen Targets
0.19Weak
multiple myelomaOpen Targets
0.19Weak
cutaneous melanomaOpen Targets
0.19Weak
colon adenocarcinomaOpen Targets
0.19Weak
colorectal adenocarcinomaOpen Targets
0.19Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets1
MOGAMULIZUMABApproved
C-C chemokine receptor type 4 cross-linking agent
adult T-cell leukemia/lymphoma
Related Genes
CCL8Protein interaction100%CCL4Protein interaction94%GRK2Protein interaction91%CCL5Protein interaction89%CCL21Protein interaction88%CCL3Protein interaction88%
Tissue Expression6 tissues
Lung
100%
Bone Marrow
79%
Liver
20%
Heart
14%
Ovary
13%
Brain
4%
Gene Interaction Network
Click a node to explore
CCR4CCL8CCL4GRK2CCL5CCL21CCL3
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt P51679
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.81LoF Tolerant
pLIⓘ
0.05Tolerant
Observed/Expected LoF0.49 [0.31–0.81]
RankingsWhere CCR4 stands among ~20K protein-coding genes
  • #3,817of 20,598
    Most Researched123 · top quartile
  • #925of 1,025
    FDA-Approved Drug Targets1
  • #6,782of 17,882
    Most Constrained (LOEUF)0.81
Genes detectedCCR4
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex.
PMID: 27558897
Nat Commun · 2016
1.00
2
Specific recognition and ubiquitination of translating ribosomes by mammalian CCR4-NOT.
PMID: 37653243
Nat Struct Mol Biol · 2023
0.90
3
CCR4-NOT differentially controls host versus virus poly(a)-tail length and regulates HCMV infection.
PMID: 37846490
EMBO Rep · 2023
0.80
4
Chemokines in allergy.
PMID: 14561210
Curr Drug Targets Inflamm Allergy · 2002
0.70
5
Structure and assembly of the NOT10:11 module of the CCR4-NOT complex.
PMID: 37460791
Commun Biol · 2023
0.60